Outset Medical (OM)
Outset Medical on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus.
793K
Short interest
settlement 2026-09-30
5.9
Days to cover
-0.2 days vs prior
40.6%
Short share of volume
2026-10-09
1,183
Fails to deliver
settlement 2026-09-09
Wed 16 Jun
Next earnings
estimated date
$824K
Insider flow, 90 days
2 buys, 3 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in OM is 792,696 shares, down 108,986 shares over the last month. Over the last 48 readings it ranged from 561,827 shares (15 May 2025) to 11,817,649 shares (14 March 2025). The latest reading sits at the bottom of that range. At the reported average volume of 134K shares a day that is 5.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/om" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 792,696 | -10.9% | 133,657 | 5.93 |
| 2026-09-15 | 889,575 | -1.3% | 143,886 | 6.18 |
| 2026-08-31 | 901,682 | -3.7% | 129,027 | 6.99 |
| 2026-08-14 | 936,341 | -18.0% | 156,913 | 5.97 |
| 2026-07-31 | 1,142,402 | -6.1% | 103,656 | 11.02 |
| 2026-07-15 | 1,216,685 | -18.5% | 193,746 | 6.28 |
| 2026-06-30 | 1,493,147 | -24.2% | 456,798 | 3.27 |
| 2026-06-15 | 1,970,839 | -11.3% | 185,753 | 10.61 |
| 2026-05-29 | 2,223,191 | +8.2% | 168,323 | 13.21 |
| 2026-05-15 | 2,054,656 | +2.2% | 215,360 | 9.54 |
| 2026-04-30 | 2,010,092 | -3.7% | 130,237 | 15.43 |
| 2026-04-15 | 2,088,243 | +7.3% | 103,782 | 20.12 |
| 2026-03-31 | 1,945,946 | -7.1% | 146,523 | 13.28 |
| 2026-03-13 | 2,094,187 | +9.3% | 262,272 | 7.98 |
| 2026-02-27 | 1,915,455 | -13.6% | 247,824 | 7.73 |
| 2026-02-13 | 2,217,364 | -2.2% | 350,037 | 6.33 |
| 2026-01-30 | 2,267,637 | -1.1% | 414,839 | 5.47 |
| 2026-01-15 | 2,293,147 | -1.4% | 2,963,978 | 1.00 |
| 2025-12-31 | 2,326,008 | +4.7% | 483,835 | 4.81 |
| 2025-12-15 | 2,221,361 | +4.8% | 512,893 | 4.33 |
| 2025-11-28 | 2,118,659 | +1.1% | 621,351 | 3.41 |
| 2025-11-14 | 2,096,697 | +21.3% | 978,307 | 2.14 |
| 2025-10-31 | 1,728,691 | -11.2% | 265,801 | 6.50 |
| 2025-10-15 | 1,946,640 | +12.9% | 313,345 | 6.21 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of OM volume is 40.6%, down 9.8 points over the last five sessions. Over the last 30 readings it ranged from 23.8% (25 September 2026) to 80.3% (1 October 2026). The latest reading is 11.8 points below the 30-session average of 52.4%, on 22K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 9K | 22K | 40.6% | 0 |
| 2026-10-08 | 19K | 42K | 44.5% | 21 |
| 2026-10-07 | 30K | 46K | 66.2% | 0 |
| 2026-10-06 | 28K | 60K | 46.8% | 0 |
| 2026-10-05 | 51K | 99K | 51.1% | 0 |
| 2026-10-02 | 102K | 202K | 50.4% | 62 |
| 2026-10-01 | 351K | 437K | 80.3% | 2,878 |
| 2026-09-30 | 15K | 42K | 34.9% | 0 |
| 2026-09-29 | 19K | 59K | 32.4% | 0 |
| 2026-09-28 | 46K | 76K | 60.4% | 27 |
| 2026-09-25 | 17K | 73K | 23.8% | 0 |
| 2026-09-24 | 51K | 123K | 41.2% | 100 |
| 2026-09-23 | 16K | 35K | 45.8% | 0 |
| 2026-09-22 | 35K | 62K | 55.9% | 15 |
| 2026-09-21 | 22K | 54K | 40.7% | 0 |
| 2026-09-18 | 47K | 68K | 69.4% | 25 |
| 2026-09-17 | 20K | 29K | 67.7% | 0 |
| 2026-09-16 | 16K | 31K | 52.3% | 0 |
| 2026-09-15 | 44K | 98K | 44.9% | 0 |
| 2026-09-14 | 53K | 72K | 74.1% | 0 |
| 2026-09-11 | 22K | 40K | 54.3% | 0 |
| 2026-09-10 | 32K | 66K | 48.7% | 0 |
| 2026-09-09 | 64K | 96K | 67.2% | 0 |
| 2026-09-08 | 50K | 173K | 28.7% | 0 |
| 2026-09-04 | 20K | 35K | 56.9% | 0 |
| 2026-09-03 | 26K | 39K | 66.8% | 0 |
| 2026-09-02 | 17K | 32K | 53.3% | 0 |
| 2026-09-01 | 36K | 49K | 73.7% | 0 |
| 2026-08-31 | 14K | 29K | 48.3% | 0 |
| 2026-08-28 | 35K | 68K | 51.6% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 September 2026, the fails-to-deliver balance in OM is 1,183 shares, up 1,181 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (15 July 2026) to 16,838 shares (2 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-09 | 1,183 | $3.47 | $4K |
| 2026-08-25 | 2 | $4.19 | $8 |
| 2026-08-04 | 1,087 | $4.99 | $5K |
| 2026-07-29 | 749 | $4.72 | $4K |
| 2026-07-28 | 47 | $4.32 | $203 |
| 2026-07-15 | 1 | $4.54 | $5 |
| 2026-07-10 | 169 | $4.45 | $752 |
| 2026-07-02 | 16,838 | $5.10 | $86K |
| 2026-06-30 | 4,369 | $4.33 | $19K |
| 2026-06-29 | 1,875 | $4.58 | $9K |
| 2026-06-15 | 140 | $4.49 | $629 |
| 2026-06-02 | 59 | $4.91 | $290 |
| 2026-05-29 | 655 | $5.01 | $3K |
| 2026-05-28 | 8 | $4.39 | $35 |
| 2026-05-26 | 27 | $4.32 | $117 |
| 2026-05-20 | 1,335 | $3.86 | $5K |
| 2026-05-18 | 10,658 | $3.63 | $39K |
| 2026-05-14 | 820 | $3.89 | $3K |
| 2026-05-12 | 122 | $3.65 | $445 |
| 2026-05-11 | 3,752 | $3.70 | $14K |
| 2026-05-08 | 10,791 | $4.68 | $51K |
| 2026-05-07 | 5,602 | $4.51 | $25K |
| 2026-05-06 | 4,236 | $4.77 | $20K |
| 2026-05-05 | 3,908 | $4.33 | $17K |
| 2026-04-30 | 9,058 | $4.18 | $38K |
| 2026-04-07 | 1,316 | $4.08 | $5K |
| 2026-03-31 | 1,975 | $3.61 | $7K |
| 2026-03-18 | 4,862 | $3.61 | $18K |
| 2026-03-17 | 10,176 | $3.35 | $34K |
| 2026-03-16 | 7,813 | $3.26 | $25K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONOver the last 90 days OM insiders reported 2 open-market buys ($870K) against 3 sells ($47K), so the dollar flow leans toward buying. Latest filing: Leonard Braden Michael (10% owner) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Leonard Braden Michael | 10% owner | Buy | 17K | $3.88 | $64K | 2.8M |
| 2026-10-01 | Leonard Braden Michael | 10% owner | Buy | 228K | $3.53 | $806K | 2.7M |
| 2026-08-17 | Trigg Leslie | Chair and CEO | Sell | 3K | $4.39 | $15K | 195K |
| 2026-08-17 | Gaeta Renee | Chief Financial Officer | Sell | 5K | $4.39 | $20K | 181K |
| 2026-08-17 | Brottem John L. | General Counsel | Sell | 3K | $4.39 | $12K | 87K |
| 2026-06-26 | Trigg Leslie | Chair and CEO | Grant | 99K | $0.00 | $0 | 198K |
| 2026-06-26 | Gaeta Renee | Chief Financial Officer | Grant | 72K | $0.00 | $0 | 185K |
| 2026-06-26 | Brottem John L. | General Counsel | Grant | 60K | $0.00 | $0 | 90K |
| 2026-06-04 | Prange Karen | Director | Grant | 11K | $0.00 | $0 | 29K |
| 2026-06-04 | OBOYLE KEVIN C | Director | Grant | 11K | $0.00 | $0 | 35K |
| 2026-06-04 | LANG BRENT D. | Director | Grant | 11K | $0.00 | $0 | 29K |
| 2026-06-04 | HACKETT PATRICK T | Director | Grant | 11K | $0.00 | $0 | 106K |
| 2026-06-04 | GROSSMAN D KEITH | Director | Grant | 11K | $0.00 | $0 | 25K |
| 2026-06-04 | Drexler Karen | Director | Grant | 11K | $0.00 | $0 | 21K |
| 2026-06-03 | Gaeta Renee | Chief Financial Officer | Sell | 18K | $4.94 | $87K | 114K |
| 2026-05-15 | Leonard Braden Michael | 10% owner | X | 323K | $5.00 | $1.6M | 2.5M |
| 2026-05-15 | Trigg Leslie | Chair and CEO | Sell | 3K | $3.70 | $13K | 99K |
| 2026-05-15 | Nash Marc | EVP Operations R&D & Service | Sell | 2K | $3.70 | $6K | 38K |
| 2026-05-15 | Brottem John L. | General Counsel | Sell | 3K | $3.70 | $10K | 30K |
| 2026-05-11 | Leonard Braden Michael | 10% owner | X | 97K | $5.00 | $485K | 2.2M |
| 2026-05-08 | Leonard Braden Michael | 10% owner | X | 198K | $5.00 | $988K | 2.1M |
| 2026-04-06 | Elliott Derick A. | EVP, Commercial | Grant | 96K | $0.00 | $0 | 96K |
| 2026-02-17 | Trigg Leslie | Chair and CEO | Sell | 3K | $3.35 | $11K | 102K |
| 2026-02-17 | Nash Marc | EVP Operations R&D & Service | Sell | 2K | $3.35 | $6K | 40K |
| 2026-02-17 | Brottem John L. | General Counsel | Sell | 3K | $3.35 | $10K | 33K |
| 2026-01-21 | Trigg Leslie | Chair and CEO | Sell | 2K | $5.05 | $11K | 106K |
| 2026-01-21 | Nash Marc | EVP Operations R&D & Service | Sell | 980 | $4.98 | $5K | 42K |
| 2026-01-21 | Brottem John L. | General Counsel | Sell | 1K | $5.01 | $6K | 36K |
| 2026-01-20 | Trigg Leslie | Chair and CEO | Sell | 12K | $5.12 | $60K | 108K |
| 2026-01-20 | Nash Marc | EVP Operations R&D & Service | Sell | 5K | $5.12 | $28K | 43K |
| 2026-01-20 | Brottem John L. | General Counsel | Sell | 9K | $5.12 | $48K | 37K |
| 2026-01-09 | Prange Karen | Director | Grant | 19K | $0.00 | $0 | 19K |
| 2026-01-07 | Trigg Leslie | Chair and CEO | Sell | 2K | $4.27 | $8K | 120K |
| 2026-01-07 | Nash Marc | EVP Operations R&D & Service | Sell | 108 | $4.27 | $461 | 48K |
| 2026-01-07 | Brottem John L. | General Counsel | Sell | 224 | $4.27 | $956 | 46K |
| 2025-12-01 | Drexler Karen | Director | Sell | 2K | $4.37 | $7K | 11K |
| 2025-11-17 | Trigg Leslie | Chair and CEO | Sell | 916 | $4.60 | $4K | 121K |
| 2025-11-17 | Nash Marc | EVP Operations R&D & Service | Sell | 247 | $4.60 | $1K | 48K |
| 2025-11-17 | Brottem John L. | General Counsel | Sell | 388 | $4.60 | $2K | 46K |
| 2025-08-25 | Nash Marc | EVP, R&D, Operations and Serv. | Grant | 6K | $0.00 | $0 | 49K |
| 2025-08-15 | Trigg Leslie | Chair and CEO | Sell | 904 | $12.88 | $12K | 122K |
| 2025-08-15 | Nash Marc | SVP Operations and R&D | Sell | 243 | $12.88 | $3K | 43K |
| 2025-08-15 | Brottem John L. | General Counsel | Sell | 383 | $12.88 | $5K | 47K |
| 2025-06-10 | Gaeta Renee | Chief Financial Officer | Grant | 131K | $0.00 | $0 | 131K |
| 2025-06-10 | Trigg Leslie | Chair and CEO | Grant | 65K | $0.00 | $0 | 123K |
| 2025-06-10 | Brottem John L. | General Counsel | Grant | 36K | $0.00 | $0 | 47K |
| 2025-06-10 | Nash Marc | SVP Operations and R&D | Grant | 30K | $0.00 | $0 | 43K |
| 2025-06-02 | Drexler Karen | Director | Grant | 9K | $0.00 | $0 | 12K |
| 2025-06-02 | GROSSMAN D KEITH | Director | Grant | 9K | $0.00 | $0 | 14K |
| 2025-06-02 | HACKETT PATRICK T | Director | Grant | 9K | $0.00 | $0 | 95K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON21 Form 144 notices on file for OM worth $356K at the prices reported; 3 in the last 90 days worth $47K. Latest: Trigg Leslie filed on 2026-08-14 to sell 3,344 shares ($15K) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-14 | Trigg LeslieOfficer | 3K | $15K | 0.018% | 2026-08-17 | Morgan Stanley Smith Barney LLC |
| 2026-08-14 | Gaeta ReneeOfficer | 4K | $20K | 0.024% | 2026-08-17 | Morgan Stanley Smith Barney LLC |
| 2026-08-14 | Brottem John L.Officer | 3K | $12K | 0.014% | 2026-08-17 | Morgan Stanley Smith Barney LLC |
| 2026-06-03 | Gaeta ReneeOfficer | 18K | $87K | 0.095% | 2026-06-03 | Morgan Stanley Smith Barney LLC |
| 2026-05-15 | Trigg LeslieOfficer | 3K | $13K | 0.019% | 2026-05-15 | Morgan Stanley Smith Barney LLC |
| 2026-05-15 | Nash MarcOfficer | 2K | $6K | 0.009% | 2026-05-15 | Morgan Stanley Smith Barney LLC |
| 2026-05-15 | Brottem John L.Officer | 3K | $10K | 0.014% | 2026-05-15 | Morgan Stanely Smith Barney LLC |
| 2026-02-17 | Trigg LeslieOfficer | 3K | $11K | 0.018% | 2026-02-17 | Morgan Stanley Smith Barney LLC |
| 2026-02-17 | Brottem John L.Officer | 3K | $10K | 0.016% | 2026-02-17 | Morgan Stanley Smith Barney LLC |
| 2026-01-21 | Trigg LeslieOfficer | 2K | $11K | 0.012% | 2026-01-21 | Morgan Stanley Smith Barney LLC |
| 2026-01-21 | Nash MarcOfficer | 980 | $5K | 0.005% | 2026-01-21 | Morgan Stanley Smith Barney LLC |
| 2026-01-21 | Brottem John L.Officer | 1K | $6K | 0.007% | 2026-01-21 | Morgan Stanley Smith Barney LLC |
| 2026-01-20 | Trigg LeslieOfficer | 12K | $60K | 0.065% | 2026-01-20 | Morgan Stanley Smith Barney LLC |
| 2026-01-20 | Nash MarcOfficer | 5K | $28K | 0.030% | 2026-01-20 | Morgan Stanley Smith Barney LLC |
| 2026-01-20 | Brottem John L.Officer | 9K | $48K | 0.051% | 2026-01-20 | Morgan Stanley Smith Barney LLC |
| 2026-01-07 | Trigg LeslieOfficer | 2K | $8K | 0.010% | 2026-01-07 | Morgan Stanley Smith Barney LLC |
| 2026-01-07 | Nash MarcOfficer | 108 | $461 | 0.001% | 2026-01-07 | Morgan Stanley Smith Barney LLC |
| 2026-01-07 | Brottem John L.Officer | 224 | $956 | 0.001% | 2026-01-07 | Morgan Stanley Smith Barney LLC |
| 2025-11-17 | Trigg LeslieOfficer | 916 | $4K | 0.005% | 2025-11-17 | Morgan Stanley Smith Barney LLC |
| 2025-11-17 | Nash MarcOfficer | 247 | $1K | 0.001% | 2025-11-17 | Morgan Stanley Smith Barney LLC |
| 2025-11-17 | Brottem John L.Officer | 388 | $2K | 0.002% | 2025-11-17 | Morgan Stanley Smith Barney LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of OM in their latest filing, all on Schedule 13G (passive). The largest reported stake is BML Investment Partners, L.P. at 14.7% of the class (2,764,610 shares), filed 2026-10-06 for an event on 2026-10-02.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-06 | 13G/Ano. 4 | BML Investment Partners, L.P.partnership | 2.8M | 14.7% | 2026-10-02 |
| 2026-08-12 | 13G | AQR Capital Management, LLCinvestment adviser | 999K | 5.4% | 2026-06-30 |
| 2026-08-12 | 13G | AQR Capital Management Holdings, LLCparent holding company | 999K | 5.4% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | BANK OF AMERICA CORP /DE/parent holding company | 667K | 3.5% | 2026-06-30 |
| 2026-07-29 | 13G/Ano. 2 | BlackRock, Inc.parent holding company | 366K | 2.0% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 1 | Anand Parekhindividual | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Alyeska Fund GP, LLCother entity | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Alyeska Investment Group, L.P.investment adviser | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Woodline Partners LPinvestment adviser, partnership | 292K | 1.6% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 2 | Durable Capital Partners LPinvestment adviser, partnership | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Partner Asset Management, LLCparent holding company, other entity | 531K | 2.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | PFM Health Sciences, LPinvestment adviser, partnership | 531K | 2.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | PFM Health Sciences GP, LLCparent holding company, other entity | 531K | 2.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | PFM Healthcare Growth Equity I GP, LLCother entity | 531K | 2.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Brian D. Grossmanparent holding company, individual | 531K | 2.9% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 2 | T. Rowe Price Investment Management, Inc.investment adviser | 2K | 0.0% | 2025-09-30 |
13F holders
Tracked managers holding OM at their latest 13F. JSON4 of the 30 tracked managers held OM at their latest 13F, $5.3M in total at quarter-end prices. AQR Capital Management is the largest at $4.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 999K | $4.3M | 0.00% | +191K |
| Millennium Management | 2026-06-30 | 182K | $785K | 0.00% | new |
| Renaissance Technologies | 2026-06-30 | 43K | $188K | 0.00% | -179K |
| Citadel Advisors | 2026-06-30 | 11K | $48K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Outset Medical reported revenue of $31.6M, up 0.7% from the same quarter a year earlier, and net loss of $18.0M (-0.97 diluted EPS). In FY 2025 it generated -$46.3M of operating cash flow. As of 2026-06-30, cash was $35.0M against $97.6M of debt.
- Cash
- $35.0M
- Debt
- $97.6M
- Equity
- $96.3M
- Total assets
- $242.4M
- Shares outstanding
- 18,797,164
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $31.6M | -$18.0M | -56.8% | -0.97 |
| Q1 FY 2026 | 2026-03-31 | $27.9M | -$19.0M | -68.1% | -1.03 |
| Q4 FY 2025derived | 2025-12-31 | $28.9M | -$19.5M | -67.5% | n/a |
| Q3 FY 2025 | 2025-09-30 | $29.4M | -$17.8M | -60.6% | -1.00 |
| Q2 FY 2025 | 2025-06-30 | $31.4M | -$18.5M | -59.0% | -1.04 |
| Q1 FY 2025 | 2025-03-31 | $29.8M | -$25.8M | -86.7% | -3.66 |
| Q4 FY 2024derived | 2024-12-31 | $29.5M | -$25.6M | -87.0% | n/a |
| Q3 FY 2024 | 2024-09-30 | $28.7M | -$27.9M | -97.5% | -8.02 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $119.5M | -$81.7M | -$46.3M | $798K | n/a | n/a |
| FY 2024 | 2024-12-31 | $113.7M | -$128.0M | -$116.3M | $912K | n/a | n/a |
| FY 2023 | 2023-12-31 | $130.4M | -$172.8M | -$131.4M | $3.4M | n/a | n/a |
| FY 2022 | 2022-12-31 | $115.4M | -$163.0M | -$145.7M | $8.3M | n/a | n/a |
| FY 2021 | 2021-12-31 | $102.6M | -$131.9M | -$130.3M | $3.1M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-04 from the cover page.
What this page is
Outset Medical in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Outset Medical (OM), SEC CIK 1484612, listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-09.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-06.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-06-17.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1484612Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as electromedical & electrotherapeutic apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of OM is sold short?
What is OM's daily short volume?
Does OM have fails to deliver?
Are OM insiders buying or selling?
Have OM insiders filed to sell?
Who owns 5% or more of OM?
What did OM report last quarter?
Which tracked 13F managers own OM?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.